netFormulary West Hertfordshire Hospitals NHS
NHS Trust  
 Search
 Formulary Chapter 25: A2 - Borderline substances including Specialist Feeds - Full Chapter
Notes:
Reviewed 2015
Chapter Links...
 Details...
A2.07  Expand sub section  Nutritional supplements for metabolic diseases
A2.07  Expand sub section  Glutaric aciduria (type 1)
A2.07  Expand sub section  Glucogen storage disease
A2.07  Expand sub section  Homocystinuria or hypermethioninaemia
A2.07  Expand sub section  Hyperlysinamia to top
A2.07  Expand sub section  sovaleric acidaemia
A2.07  Expand sub section  Maple syrup urine disease
A2.07  Expand sub section  Methylmalonic or propionic acidaemia
A2.07  Expand sub section  Other inborn errors of metabolism
A2.07  Expand sub section  Phenylketonuria to top
A2.07  Expand sub section  Tyrosinaemia
A2.07  Expand sub section  Urea cycle disorders (other than arginase deficiency)
 ....
 Non Formulary Items
Add-Ins

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Easiphen

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Lophlex

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Loprofin PKU Drink

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Low protein / phenylalanine free foods

View adult BNF View SPC online View childrens BNF
Non Formulary
Link  ABCS approved products for PKU
 
L-Tyrosine

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Milupa PKU 2-prima

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Milupa PKU 2-secunda

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Milupa PKU 3-advanta

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Phlexy-10 Exchange System

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Phlexy-Vits

View adult BNF View SPC online View childrens BNF
Non Formulary
 
PK Aid-4

View adult BNF View SPC online View childrens BNF
Non Formulary
 
PKU Anamix Infant

View adult BNF View SPC online View childrens BNF
Non Formulary
 
PKU Anamix Junior

View adult BNF View SPC online View childrens BNF
Non Formulary
 
PKU Anamix Junior LQ

View adult BNF View SPC online View childrens BNF
Non Formulary
 
PKU cooler10

View adult BNF View SPC online View childrens BNF
Non Formulary
 
PKU cooler15

View adult BNF View SPC online View childrens BNF
Non Formulary
 
PKU cooler20

View adult BNF View SPC online View childrens BNF
Non Formulary
 
PKU express

View adult BNF View SPC online View childrens BNF
Non Formulary
 
PKU gel

View adult BNF View SPC online View childrens BNF
Non Formulary
 
PKU Lophlex LQ 10

View adult BNF View SPC online View childrens BNF
Non Formulary
 
PKU Loplex LQ 20

View adult BNF View SPC online View childrens BNF
Non Formulary
 
PKU Start

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Sno-Pro

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Tyrosine Amino Acid Supplement

View adult BNF View SPC online View childrens BNF
Non Formulary
 
XP Maxamaid

View adult BNF View SPC online View childrens BNF
Non Formulary
 
XP Maxamum

View adult BNF View SPC online View childrens BNF
Non Formulary
 
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Double Red

Not recommended for use because of lack of evidence of clinical effectiveness, cost effectiveness or safety.

Drugs which have been evaluated and rejected by the Herts Medicines Management Committee (HMMC)
Drugs defined as ‘Low Priority’ by the Herts Priorities Committee
New drugs which have not as yet been evaluated by the HMMC
Any drug not listed in the West Herts Formulary  

  

Red

Drugs which should only be prescribed in secondary care by a specialist.

Require specialist knowledge and/or equipment for patient selection and initiation
Require long term on-going monitoring and dose adjustment to ensure efficacy and minimise toxicity by a specialist
Designated as “hospital only“ by product licence, NICE, DoH or BNF
May need further evaluation by a specialist
Are hospital initiated clinical trial materials  

  

Red Specialist Centre

Specialist Centre initiation  

Amber Protocol

Drugs which should be initiated in secondary care by the specialist with follow-on prescription and monitoring according to a drug specific Shared Care Protocol (SCP). Prescribing may be continued in primary care following the SCP Require specialist knowledge and/or equipment for patient selection and initiation Require short or medium term (eg. 3 to 6 months) specialist monitoring of efficacy or toxicity. The need for stabilisation will vary with different drugs and patients, but is usually a minimum of 3 months (see principles for shared care) or if different as stated in the protocol Require significant long term monitoring Require ongoing communication between the GP and the specialist Have clearly defined consultant, GP and patient responsibilities documented in a shared care protocol   

Amber Initiation

Drugs suitable for primary care prescribing following specialist initiation  

Green

Drugs for which primary care prescribers would normally take full responsibility for prescribing and monitoring

Drugs not included in the Traffic Light list but included on joint formulary.
New drugs classified as red or amber but as greater experience regarding their safety and efficacy is established may move to Green after re-consideration by the HHMC.  

  

netFormulary